Fig. 4

Cost-effectiveness acceptability curves for costs per QALY using different periods and with/without intervention costs. Note: The curves indicate the probability (y-axis) of DOMUS being cost-effective compared the usual care, given a specific threshold value (x-axis) for an additional QALY. Controlled for baseline utility Source: DOMUS trial data and administrative data from Statistic Denmark and the National eHealth Authority. EQORT for patients’ QALYs